Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01910350 · ClinicalTrials.gov registry record · NA
Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening
A NA study of Breast Cancer and Cervical Cancer, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 516
- Enrollment target
- 1
- Study location
NCT01910350: Completed NA study of Breast Cancer and Cervical Cancer, sponsored by Michigan State University.
NCT01910350 is a NA study of Breast Cancer and Cervical Cancer that has completed, run by Michigan State University. The registered enrollment target is 516 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01910350, a NA study of Breast Cancer and Cervical Cancer, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 516 participants
- Enrollment target
- 1
- Study location
Study Summary
1\) To determine if the Kin KeeperSM Cancer Prevention Intervention increases first time and appropriately timed breast cancer screening rates among Black, Latina and Arab women; 2) To determine if the Kin KeeperSM Cancer Prevention Intervention increase first time and appropriately time cervical cancer screening rates among Black, Latina and Arab women; 3) To measure functional cancer literacy over time at the individual and familial level and 4) Assess rates of healthcare utilization cost among women in the Kin KeeperSM intervention and control-comparison groups.
Primary Outcome
Participants will complete measures every 6 months (baseline, 12 mo., 18 mo., 24 mo., 30 mo. \& 36 mo.)to measure increases in screening rates for experimental vs. control group.
Conditions Studied
Interventions
- OTHER Standard of care
- BEHAVIORAL Kin KeeperSM Cancer Prevention Intervention
Study Locations (1)
Michigan
- Michigan State University - East Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT01910350 record still lists
NCT01910350 is an interventional study that assigns participants to a tested intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT01910350 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01910350 about?
NCT01910350 is a clinical study titled "Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening". 1\) To determine if the Kin KeeperSM Cancer Prevention Intervention increases first time and appropriately timed breast cancer screening rates among Black, Latina and Arab women; 2) To determine if the Kin KeeperSM Cancer Prevention Intervention increase first time and appropriately time cervical ca...
What is the current status of trial NCT01910350?
This trial is currently completed. It is a NA study. The enrollment target is 516 participants. The study started on 2010-07. Estimated completion is 2015-06.
What conditions does trial NCT01910350 study?
This clinical trial studies the following conditions: Breast Cancer, Cervical Cancer.
What interventions are being tested in trial NCT01910350?
The interventions under investigation include: Standard of care (OTHER), Kin KeeperSM Cancer Prevention Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01910350?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01910350 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01910350's enrollment target sits among peer trials
516 189th of 1224 higher than 1,036 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia